 Your new post is loading...
Your new post is loading...
Scoop.it!
However, none had autoimmune markers such as anti-nuclear antibodies (ANA), antismooth muscle, and scleroderma (Scl-70) antibody. Histological examination was necessary to make the diagnosis in three patients, which ... 
No comment yet.
Sign up to comment
Scoop.it!
MedPage Today
Scoop.it!
Marker Predicts Poor Outcomes in Scleroderma MedPage Today Patients with systemic sclerosis who had high levels of circulating CXCL4 were more than three times as likely to develop early pulmonary fibrosis as shown by a 30% or more loss in forced...
Scoop.it!
Rheumatology Medical Article: Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort, systematic review and meta-analysis (#scleroderma I just have added an exclusive commentary on our manuscript on anti...
Scoop.it!
Early systemic sclerosis (SSc) is characterized by Raynaud's phenomenon together with scleroderma marker autoantibodies and/or a scleroderma pattern at capillaroscopy and no other distinctive feature of SSc.
|
Scoop.it!
The Golgi complex is an elaborate cytoplasmic organelle that has a prominent function in the processing, transporting, and sorting of intracellular proteins subsequent to their synthesis in the rough endoplasmic reticulum.
Gilbert C FAURE's insight:
got one scleroderma and sjogren's patient with very unusual triple substrate pattern and difficult to resolve, mearly misleading aspect on HEP-2 associating centromeric and Golgi labelling.
Scoop.it!
|
|
Scooped by
Gilbert C FAURE
December 19, 2013 3:59 PM
|
Scoop.it!
The complex interplay between the immune system and cancer -- specifically, an anti-tumor immune response that leads to tissue damage -- may underlie the development of scleroderma, current research s (Tumors May Give Rise to Autoimmunity (CME/CE)...
|
|
Scooped by
Gilbert C FAURE
October 12, 2013 3:09 PM
|
Scoop.it!
Getting Under the Skin of Scleroderma
Howard Hughes Medical Institute
To see if they could stop the observed cascade of events, Dietz's group turned to an antibody that promotes the interaction between integrins and their matrix-binding partners.
mouse model of scleroderma
|
|
Scooped by
Gilbert C FAURE
December 6, 2012 2:49 PM
|
Scoop.it!
Harvard University Expert to Host Scleroderma Webinar: New Directions for ...The Herald | HeraldOnline.comThis free webinar will describe current scleroderma clinical trials and new treatments on the horizon.
